Also, it has been described that FGF-2 secreted by glioma cells augments the function of blood barrier function and contributes to therapy resistance [152], suggesting that FGF-2 has a further role in blood vessels already formed in the perivascular niche. The gene discussed is FGF2; the disease is central nervous system cancer.